InvestSMART

Imagion Biosystems Limited (ASX: IBX) - Announcements

Current share price for IBX : $0.010 0.001 (4.76%)+

ASX company news and announcements for Imagion Biosystems Limited (IBX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imagion Biosystems Limited (IBX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Imagion Biosystems Limited (IBX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Imagion Biosystems Limited (IBX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$8 Appendix 3B 4 Oct 2019 4:30PM $0.037 $0.010 fallen by 72.97%
$8 Imagion Biosystems Investor Update 2 Oct 2019 9:15AM $0.046 $0.010 fallen by 78.26%
$8 Cleansing Notice 30 Sep 2019 3:32PM $0.049 $0.010 fallen by 79.59%
$8 Appendix 3B 30 Sep 2019 3:31PM $0.049 $0.010 fallen by 79.59%
$8 Investor Presentation 9 Sep 2019 9:29AM $0.042 $0.010 fallen by 76.19%
$8 MagSense Utility as a Potential MRI Contrast Agent 9 Sep 2019 9:09AM $0.042 $0.010 fallen by 76.19%
$8 Appendix 4D and Half Year Report 30 Aug 2019 8:43AM $0.042 $0.010 fallen by 76.19%
$8 Imagion Biosystem's Newsletter 23 Aug 2019 9:03AM $0.045 $0.010 fallen by 77.78%
$8 IBX Regulatory Communications Update 6 Aug 2019 8:46AM $0.043 $0.010 fallen by 76.74%
$8 Appendix 4C - quarterly 30 Jul 2019 9:07AM $0.043 $0.010 fallen by 76.74%
$8 Change in substantial holding 26 Jul 2019 10:45AM $0.045 $0.010 fallen by 77.78%
$8 Change in substantial holding 25 Jul 2019 5:00PM $0.047 $0.010 fallen by 78.72%
$8 Imagion Biosystems receives A$2 million in R&D tax incentive 25 Jul 2019 9:12AM $0.044 $0.010 fallen by 77.27%
$8 FDA Breakthrough Device Designation 18 Jul 2019 9:46AM $0.020 $0.010 fallen by 50%
$8 Final Director's Interest Notice 28 Jun 2019 9:14AM $0.017 $0.010 fallen by 41.18%
$8 Director Resignation - Dr. John Hazle 27 Jun 2019 3:45PM $0.017 $0.010 fallen by 41.18%
$8 Appendix 3Y x 5 27 Jun 2019 3:42PM $0.017 $0.010 fallen by 41.18%
$8 Ceasing to be a substantial holder 25 Jun 2019 5:35PM $0.017 $0.010 fallen by 41.18%
$8 Appendix 3B 24 Jun 2019 10:38AM $0.017 $0.010 fallen by 41.18%
$8 Release of Securities Subject to Escrow 7 Jun 2019 8:27AM $0.024 $0.010 fallen by 58.33%
$8 Results of Annual General Meeting 31 May 2019 12:37PM $0.025 $0.010 fallen by 60%
$8 Chairman's Address to Shareholders at Annual General Meeting 31 May 2019 10:43AM $0.025 $0.010 fallen by 60%
$8 Imagion Biosystems successfully completes toxicology study 23 May 2019 8:29AM $0.024 $0.010 fallen by 58.33%
$8 Non-Deal Roadshow Presentation 21 May 2019 5:05PM $0.023 $0.010 fallen by 56.52%
$8 Imagion Biosystems receives R&D Advanced Overseas Finding 13 May 2019 1:39PM $0.023 $0.010 fallen by 56.52%

576 - 600 of 686 results

Page 24 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.